| Reconciliation of Net Tax Provision |
The net tax provision differs from that expected by applying the combined federal and provincial tax rates of 27.0% (March 31, 2025 – 27.0%) to income (loss) before income tax for the following items: | | | | | | | | | | | March 31, 2026 | March 31, 2025 | | $ | $ | Income (loss) before tax from continuing operations | (56,524) | | 31,295 | | Income (loss) before tax from discontinued operations | (73,866) | | (25,060) | | | Income (loss) before tax | (130,390) | | 6,235 | | | Combined federal and provincial rate | 27.0 | % | 27.0 | % | | Expected tax recovery (expense) | 35,205 | | (1,683) | | | | | | | | | Non-taxable (non-deductible) income (expenses) | (4,826) | | (3,071) | | | Non-taxable (non-deductible) portion of capital items | 3,165 | | 3,620 | | | | | | | | | Tax impact on divestitures | 2,695 | | — | | | Difference in statutory tax rate | (751) | | (2,400) | | | Effect of change in tax rates | (1,404) | | 1,530 | | | Changes in deferred tax benefits not recognized | (38,821) | | 1,933 | | | Change in tax legislation and other | (837) | | (4,573) | | | Income tax expense | (5,574) | | (4,644) | | | Effective tax rate | 4 | % | (74) | % | | Income tax expense from continuing operations | (2,095) | | (4,245) | | | Income tax expense from discontinued operations | (3,479) | | (399) | | | (5,574) | | (4,644) | |
|
| Deferred Tax Assets (Liabilities) and Temporary Differences |
Movements in deferred tax assets (liabilities) at March 31, 2026 and March 31, 2025 are comprised of the following: | | | | | | | | | | | | | | | | | | | | | | | Balance, March 31, 2025 | Discontinued operations | Recovered through (charged to) earnings | Reclass for liability for asset held for sale | Recovered through (charged to) other comprehensive income | | Balance, March 31, 2026 | | $ | $ | $ | $ | $ | | $ | | Deferred tax assets | | | | | | | | | Non-capital losses | 28,276 | | 1,075 | | (7,310) | | (1,075) | | 70 | | | 21,036 | | | Capital losses | 327 | | 59 | | — | | (59) | | — | | | 327 | | | Finance costs | 564 | | 18 | | (564) | | (18) | | — | | | — | | | | | | | | | | | | | | | | | | | | | | | | | | | Leases | 5,345 | | 869 | | (2,944) | | (869) | | 38 | | | 2,439 | | | Others | 60 | | — | | — | | — | | — | | | 60 | | | Total deferred tax assets | 34,572 | | 2,021 | | (10,818) | | (2,021) | | 108 | | | 23,862 | | | | | | | | | | | Deferred tax liabilities | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Intangible assets | (8,641) | | (59) | | 1,383 | | 59 | | (157) | | | (7,415) | | | Property, plant and equipment | (18,534) | | (5,509) | | 11,061 | | 5,509 | | 50 | | | (7,423) | | | Inventory | (5,138) | | — | | (4,244) | | — | | 178 | | | (9,204) | | | Biological assets | 777 | | — | | 2,485 | | — | | — | | | 3,262 | | | Others | (714) | | 68 | | 189 | | (68) | | (99) | | | (624) | | | Total deferred tax liabilities | (32,250) | | (5,500) | | 10,874 | | 5,500 | | (28) | | | (21,404) | | | | | | | | | | | Net deferred tax assets (liabilities) | 2,322 | | (3,479) | | 56 | | 3,479 | | 80 | | | 2,458 | |
| | | | | | | | | | | | | | | | | | | | Balance, March 31, 2024 | | Recovered through (charged to) earnings | Recovered through (charged to) other comprehensive income | Recovered through (charged to) equity | Balance, March 31, 2025 | | $ | | $ | $ | $ | $ | | Deferred tax assets | | | | | | | | Non-capital losses | 23,740 | | | 4,293 | | 243 | | — | | 28,276 | | | Capital losses | 56 | | | 271 | | — | | — | | 327 | | | Finance costs | 64 | | | 500 | | — | | — | | 564 | | | Investment tax credit | — | | | — | | — | | — | | — | | | | | | | | | | Derivatives | — | | | — | | — | | — | | — | | | Leases | 6,238 | | | (989) | | 96 | | — | | 5,345 | | | Others | (109) | | | 147 | | 22 | | — | | 60 | | | Total deferred tax assets | 29,989 | | | 4,222 | | 361 | | — | | 34,572 | | | | | | | | | | Deferred tax liabilities | | | | | | | | Convertible debenture | — | | | — | | — | | — | | — | | | Investment in associates | — | | | — | | — | | — | | — | | | | | | | | | | Intangible assets | (7,742) | | | (497) | | (402) | | — | | (8,641) | | | Property, plant and equipment | (12,380) | | | (6,206) | | 52 | | — | | (18,534) | | | Inventory | (5,709) | | | 603 | | (32) | | — | | (5,138) | | | Biological assets | (4,863) | | | 5,640 | | — | | — | | 777 | | | Others | (142) | | | (610) | | 38 | | — | | (714) | | | Total deferred tax liabilities | (30,836) | | | (1,070) | | (344) | | — | | (32,250) | | | | | | | | | | Net deferred tax liabilities | (847) | | | 3,152 | | 17 | | — | | 2,322 | |
Deferred tax assets (liabilities) as presented in the consolidated statements of financial position:
| | | | | | | | | | March 31, 2026 | March 31, 2025 | | $ | $ | | Deferred tax assets | 2,458 | | 4,219 | | | Deferred tax liabilities | — | | 1,897 | | | Net deferred tax assets (liabilities) | 2,458 | | 2,322 | |
Deferred tax assets have not been recognized with respect to the following deductible temporary differences: | | | | | | | | | | March 31, 2026 | March 31, 2025 | | $ | $ | | Non-capital losses carried forward | 1,096,422 | | 1,293,859 | | | | | | Capital losses | 184,022 | | 182,749 | | | Property, plant and equipment | 209,086 | | 579,392 | | | Intangible assets | 44,740 | | 71,559 | | | Goodwill | 23,187 | | 29,021 | | | Marketable securities | 23,224 | | 23,224 | | | Investment tax credits | 1,611 | | 6,696 | | | Derivatives | 5,155 | | 4,393 | | | Capital lease obligations | 16,917 | | 21,269 | | | Other | 11,919 | | 18,003 | | | 1,616,283 | | 2,230,165 | |
The Company has income tax loss carryforwards of approximately $1,170.3 million (March 31, 2025 – $1,376.5 million) which are predominately from Canada and if unused, will expire as follows:
| | | | | | | Expiration year | | | $ | | 2027 - 2031 | 210,927 | | | 2032 - 2036 | 197,109 | | | 2037 - 2041 | 528,595 | | | 2042 - 2046 | 105,281 | | | Foreign Unlimited | 128,346 | | | 1,170,258 | |
|